Search Results | American Association for Cancer Research

1-20 of 587

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Linking Genotype to Phenotype: Bench to Bedside

Suzanne George, Monica M. Bertagnolli

Clin Cancer Res (2022) 28 (13): 2725–2727.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0027

Published: 01 July 2022

View article

Journal Articles

Shall We Dance: Evolving Partnerships of Targeted Therapies for AML

Alexander E. Perl, Paresh Vyas

Clin Cancer Res (2022) 28 (13): 2719–2721.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0279

Published: 01 July 2022

View article

Journal Articles

What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet

Roberto Salgado, Sherene Loi

Clin Cancer Res (2022) 28 (13): 2728–2729.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0783

Published: 01 July 2022

View article

Journal Articles

Biomarker Development: Bedside to Bench

Grace E. Mishkin, Elise C. Kohn

Clin Cancer Res (2022) 28 (13): 2722–2724.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0750

Published: 01 July 2022

View article

Journal Articles

Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer

Shih Yu Cindy Yang, Trevor J. Pugh, Amit M. Oza

Clin Cancer Res (2022) 28 (13): 2730–2732.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0336

Published: 01 July 2022

View article

Journal Articles

Combination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs

Sarah Cappuyns, Josep M. Llovet

Clin Cancer Res OF1.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1213

Published: 01 July 2022

View article

Journal Articles

Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise

Harry H. Yoon, Haidong Dong, Qian Shi

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0932

Published: 29 June 2022

View article

Journal Articles

Shining a FLASHlight on ultrahigh dose rate radiation and possible late toxicity

Amit Maity, Constantinos Koumenis

Clin Cancer Res clincanres.1255.2022-5-10 22:17:03.080.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1255

Published: 23 June 2022

View article

Journal Articles

PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy

Fei Shu, Salman R. Punekar, Vamsidhar Velcheti, Miguel F. Sanmamed, Jun Wang

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0541

Published: 21 June 2022

View article

Journal Articles

Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is it all about ME1?

Vivek Subbiah, Boyi Gan

Clin Cancer Res clincanres.1257.2022-5-1 22:00:31.200.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1257

Published: 21 June 2022

View article

Journal Articles

Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

David H. Henry, Robert G. Maki

Clin Cancer Res (2022) 28 (12): 2485–2487.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0884

Published: 13 June 2022

View article

Journal Articles

Predicting the Future: Machine-Based Learning for MRD Prognostication

Charlotte Pawlyn, Faith E. Davies

Clin Cancer Res (2022) 28 (12): 2482–2484.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0219

Published: 13 June 2022

View article

Journal Articles

Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNA

Bernd Kasper, Breelyn A. Wilky

Clin Cancer Res (2022) 28 (12): 2480–2481.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0738

Published: 13 June 2022

View article

Journal Articles

An Ascendant Challenge: Central Nervous System Metastases in ALK⁺ Lung Cancers

Yonina R. Murciano-Goroff, Guilherme Harada, Alexander Drilon

Clin Cancer Res (2022) 28 (12): 2477–2479.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0341

Published: 13 June 2022

View article

Journal Articles

Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer

Yuqing Zhang, Courtney W. Houchen, Min Li

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1083

Published: 07 June 2022

View article

Journal Articles

War against NRAS-Mutant Melanoma Using Targeted Therapies Remains Challenging

Stergios J. Moschos

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1256

Published: 07 June 2022

View article

Journal Articles

PD-1 Inhibition—Trouble for Subsequent TIL Therapy in Patients with Melanoma?

Eryn Blass, Patrick A. Ott

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0832

Published: 03 June 2022

View article

Journal Articles

Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment

P. Brent Ferrell, Shahram Kordasti

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1030

Published: 03 June 2022

View article

Journal Articles

Trials, Tribunals, and Opportunities for Lung Cancer KRAS^G12C Brain Metastases

Anuhya Kommalapati, Aaron S. Mansfield

Clin Cancer Res OF1–OF3.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-1137

Published: 03 June 2022

View article

Journal Articles

PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials

Shibani Nicum, Sarah P. Blagden

Clin Cancer Res (2022) 28 (11): 2201–2203.

DOI: https://doi.org/10.1158/1078-0432.CCR-22-0442

Published: 01 June 2022

View article

2 3 4 5

NARROW

Linking Genotype to Phenotype: Bench to Bedside

Shall We Dance: Evolving Partnerships of Targeted Therapies for AML

What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet

Biomarker Development: Bedside to Bench

Double Trouble: Whole-Genome Doubling Distinguishes Early from Late Ovarian Cancer

Combination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs

Impact of PD-1 Blockade in Nonresponders: Pitfalls and Promise

Shining a FLASHlight on ultrahigh dose rate radiation and possible late toxicity

PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy

Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is it all about ME1?

Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

Predicting the Future: Machine-Based Learning for MRD Prognostication

Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNA

An Ascendant Challenge: Central Nervous System Metastases in ALK⁺ Lung Cancers

Patient-Derived Organoid Pharmacotyping Guides Precision Medicine for Pancreatic Cancer

War against NRAS-Mutant Melanoma Using Targeted Therapies Remains Challenging

PD-1 Inhibition—Trouble for Subsequent TIL Therapy in Patients with Melanoma?

Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment

Trials, Tribunals, and Opportunities for Lung Cancer KRAS^G12C Brain Metastases

PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only